Last reviewed: June 21, 2026

Last updated: June 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections are administered once weekly under the skin, and choosing the correct injection site matters for both safety and medication absorption. PlexusDx patients receive detailed injection training, but understanding the anatomy behind injection placement helps you feel confident during self-administration.

Start your GLP-1 program with PlexusDx

One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.

Start your intake →

Approved Injection Sites for Semaglutide Therapy

Semaglutide can be injected into three main body areas: the abdomen, upper arm, or thigh. The abdomen offers the largest injection area and remains the most common site choice among patients. Each location has distinct advantages—the abdomen provides easier access for self-injection, while the thigh and upper arm work well for patients who prefer variety or have skin sensitivity concerns in one area.

Subcutaneous injection means the medication goes into the fatty tissue layer beneath your skin, not into muscle or a vein. This shallow placement ensures steady, consistent absorption of semaglutide over the full seven-day dosing interval. PlexusDx compounded semaglutide from licensed 503A pharmacies is formulated specifically for subcutaneous delivery, matching the same tissue-layer absorption as brand-name versions.

Abdominal Injection Site: Most Common Placement

The front of your abdomen between the ribcage and hipbones represents the preferred injection zone for most semaglutide users. This area contains adequate fatty tissue in nearly all patients and allows for easy self-visualization during injection. Many patients find abdominal injections less uncomfortable than other sites because the skin and underlying tissue tend to be less sensitive to needle penetration compared to arms or thighs.

When using your abdomen, stay at least two finger-widths away from your belly button and avoid any scars, bruises, or areas where skin appears hardened or discolored. Rotating injection sites within the abdominal area—moving 1 inch or more between weekly shots—reduces the risk of lipohypertrophy, a condition where fatty tissue thickens from repeated needle trauma at identical spots. This rotation pattern becomes especially important for patients committed to long-term semaglutide therapy.

Thigh and Upper Arm Injection Techniques

Your thigh offers ample fatty tissue, particularly on the front and outer side of the upper leg. This site works especially well for patients who prefer injecting while seated or who have limited abdominal access due to surgical scars or other conditions. The thigh remains relatively stable during injection, which can reduce anxiety for first-time users nervous about needle movement.

Upper arm injections target the back of your arm between shoulder and elbow, where subcutaneous fat provides cushioning for the needle. Unlike abdominal injections, arm injections require either the non-dominant hand to be injected by someone else or practice using your opposite hand. Some patients find upper arm injections slightly more uncomfortable than abdominal or thigh sites, though individual pain perception varies widely based on skin thickness and personal sensitivity.

Proper Site Rotation and Safety Practices

Rotating injection sites prevents skin complications and ensures consistent medication delivery. A simple rotation pattern involves choosing one body area for each week—for example, abdomen week one, thigh week two, arm week three, then back to abdomen week four. Within each chosen area, advance the injection spot 1 inch away from your previous injection location each time you use that site during its designated week.

Never inject into areas with bruising, swelling, tenderness, or hardened skin, as these signs indicate localized inflammation or lipohypertrophy requiring healing time. Before each injection, clean the skin with an alcohol wipe and allow it to dry completely—injecting into wet alcohol increases discomfort and may affect medication absorption. PlexusDx provides detailed injection guides with each semaglutide order, and your care team can review proper technique during your initial consultation. If you develop persistent lumps, redness, or pain at injection sites, contact your healthcare provider immediately, as these may indicate infection or tissue damage requiring medical evaluation.

How Injection Site Choice Affects Treatment Results

Research shows that subcutaneous semaglutide absorption remains consistent across approved injection sites—abdomen, thigh, and upper arm all deliver the medication effectively into your bloodstream. Site selection should prioritize your comfort and ability to maintain consistent weekly injections, as adherence matters more than location choice for achieving weight loss and metabolic benefits. Patients who rotate sites comfortably tend to stick with treatment longer compared to those forcing themselves to use uncomfortable locations.

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with a consistent, flat pricing structure—your dose may increase over time as your provider adjusts your treatment, but your monthly cost remains predictable. The Precision Peptide Genetic Test ($298) analyzes your GLP1R genetic variant (rs6923761) and 13 other peptide-pathway markers, potentially revealing whether you'll be a strong responder to GLP-1 therapy or might benefit from dual-compound options like GLP-Squared. Understanding your genetic predisposition helps your PlexusDx provider optimize injection strategy and medication selection from the start.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide in the same spot every week?

No—injecting in identical spots repeatedly causes lipohypertrophy, a thickening of fatty tissue that reduces medication absorption and increases discomfort. Rotate your injection site at least 1 inch away each time within the same body area, and ideally alternate between abdomen, thigh, and upper arm on a weekly cycle. PlexusDx injection guides include rotation diagrams to help you track new locations.

Is abdominal injection more effective than thigh or arm injection?

Clinical studies show no meaningful difference in semaglutide efficacy between approved injection sites—all three locations deliver consistent absorption into your bloodstream. Choose the site where you feel most comfortable administering your injection weekly, as treatment adherence matters more than location for weight loss results.

How much does compounded semaglutide cost at PlexusDx?

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with a flat-rate pricing structure across all doses. Your dose may increase over time as your provider titrates your treatment, but your monthly cost stays consistent—you're never charged more simply because your dose went up.

What should I do if my injection site becomes swollen or bruised?

Minor bruising or swelling typically resolves within a few days and doesn't require medical attention. However, if you develop persistent redness, warmth, pus, severe swelling, or hardened lumps lasting more than a week, contact your healthcare provider immediately, as these signs may indicate infection or lipohypertrophy requiring evaluation.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves